Fundraising Fox

Kevin Koch

Investor

Venture Partner at OrbiMed

Boulder, Colorado

Writes $1M – $75M checks · typically $4M

About

Kevin Koch is President and CEO of Edgewise Therapeutics, a public biotechnology company he founded. Over 12 years, the company developed 21 investigational new drugs across multiple therapeutic areas. Koch has experience in corporate strategy, investor relations, and business development within vertically integrated, research-driven organizations.

Experience

  1. Edgewise TherapeuticsPresident and CEOcurrent2017 — presentBoulder, Colorado
  2. OrbiMedVenture Partnercurrent2016 — presentNew York and San Francisco
  3. BiogenSenior Vice President, Drug Discovery, Chemical & Molecular Therapeutics2013 — 2015Cambridge, Massachusetts
  4. Array BioPharmaPresident and Chief Scientific Officer, Company Founder1998 — 2013Boulder, Colorado
  5. Array BioPharmaPresident and Chief Scientific Officer2000 — 2007Boulder, Colorado
  6. Array BioPharmaCo-Founder Array BioPharma1998 — 2000Boulder, Colorado
  7. AmgenAssociate Director, Medicinal Chemistry1995 — 1998Boulder, Colorado
  8. PfizerSenior Research Investigator1993 — 1995Central Research, Groton, Connecticut
  9. PfizerInventor1988 — 1995Central Research, Groton, Connecticut
  10. PfizerSenior Research Scientist1991 — 1993Central Research, Groton, Connecticut
  11. PfizerResearch Scientist1988 — 1991Central Research, Groton, Connecticut
  12. Ciba-Geigy CorpAssociate Scientist, Process Research1983 — 1984Summit, New Jersey

Education

  1. University of Rochester, Dept. of ChemistryPh.D., Synthetic Organic Chemistry,1988
  2. University of Rochester, Dept. of ChemistryM.S, Organic Chemistry
  3. State University of New York, Stony BrookB.S., Chemistry & Biochemistry

Skills & more

Drug Development2Medicinal Chemistry4Life Sciences3Immunology2Clinical Development7Drug Discovery6Clinical Trials1Biotechnology5

From Kevin's professional profile.

Investments

Per SEC Form D filings.

Colleagues at OrbiMed

Alexander M. Cooper
Investor at OrbiMed
Alexandria Huynh
Analyst at OrbiMed
Anat Nursella
Venture Partner at OrbiMed
Andrew P. Kanarek, CFA, CIPM
Investor at OrbiMed
Ankesh Bhansali
Investor at OrbiMed
Arun Sadhanandham
Investor at OrbiMed
Bob Smith
Investor at OrbiMed
Brendan Weber
Principal at OrbiMed

Frequently asked questions

Where does Kevin Koch work?
Kevin Koch is Venture Partner at OrbiMed.
What check size does Kevin Koch write?
Kevin Koch typically writes checks of $1M – $75M.

Founder mafias

OrbiMed mafia6

Also came through, then founded or led a company.

Peter ThompsonPartnerFounded Cleave Biosciences +4Iain DukesVenture PartnerFounded Viriom +1Tadd WesselPartnerFounded PetrichorSteven YeciesVenture PartnerFounded Javelin OncologySevgi GurkanVenture PartnerFounded Perfuse Therapeutics

Edgewise Therapeutics mafia2

Also came through, then founded or led a company.

Peter ThompsonChairman, Co-FounderFounded Cleave Biosciences +3

Shared employers

Also worked at Edgewise Therapeutics2

Marc SemigranInvestor at Broadview VenturesPeter ThompsonGeneral Partner at OrbiMed

Also worked at Biogen27

Jigar RaythathaInvestor at Third Rock VenturesRichard RansohoffVenture Partner at Third Rock VenturesIsaiah Baril-DoreInvestor at Index VenturesSteve HoltzmanBio Advisor at Amplify PartnersRoy LobbVenture Partner at Advent Life SciencesSun AltbachSenior Scientific Advisor at BOLD Longevity

+ 21 more

Also worked at Array BioPharma4

Steve TregayManaging General Partner at Mission BiocapitalLarry BurgessExecutives in Residence at GENERAL INCEPTIONKyle LefkoffGeneral Partner at Boulder VenturesJohn JoseyPartner at The Column Group

Also worked at Amgen60

Seth LieblichInvestment Team at 8VCSean BruichChief Technology Officer at Flare Capital PartnersSteph ScottVice President at Questa CapitalBeth SeidenbergFounding Managing Director at Westlake Village BioPartnersKelli McKeirnanDirector of Administration at Westlake Village BioPartnersDesmond PadhiOperating Partner at Westlake Village BioPartners

+ 54 more